Indigo Pharmaceuticals Appoints Dennis R. Cryer as Chief Medical Officer NEW YORK, Oct. 9, 2007 (PRIME NEWSWIRE) -- Manhattan-based Indigo Pharmaceuticals, Inc., a Paramount Biosciences-founded company committed to the development of new treatments for patients living with...

Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co. NEW YORK, June 1, 2007 (PRIME NEWSWIRE) -- Manhattan-based Indigo Pharmaceuticals, Inc. (Indigo), is a pharmaceutical company focused on the development of new treatments for cardiovascular diseases,...